Insmed (INSM) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

INSM Insmed

Watchlist

25.555
+0.285+1.13%

Trading Apr 24 12:38 ET

3.80BMarket Cap-4785P/E (TTM)

Intraday

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Insmed Inc : Truist Securities Initiates Coverage With Buy Rating; Target Price $48
Moomoo 24/7Apr 23 07:10 ET
Insmed Initiated at Buy by Truist Securities
Insmed Initiated at Buy by Truist Securities
Dow JonesApr 23 06:50 ET
Analysts Conflicted on These Healthcare Names: Cartesian Therapeutics (RNAC), Insmed (INSM) and BioNTech SE (BNTX)
TipRanksApr 23 06:40 ET
Express News | Truist Securities Initiates Coverage On Insmed With Buy Rating, Announces Price Target of $48
Moomoo 24/7Apr 23 06:40 ET
Analysts Offer Insights on Healthcare Companies: Insmed (INSM) and UnitedHealth (UNH)
TipRanksApr 16 13:20 ET
Insmed Is Maintained at Overweight by Barclays
Insmed Is Maintained at Overweight by Barclays
Dow JonesApr 11 09:40 ET

Comments

Meltyy

Apr 18 16:34

🎯 Ph 3 readouts in Q2 2024...

$Travere Therapeutic(TVTX.US)$ Phase 3
$CG Oncology(CGON.US)$ Phase 3
$United Therapeutics(UTHR.US)$ Phase 3
$United Therapeutics(UTHR.US)$ Phase 3
$BioCardia(BCDA.US)$ Phase 3
$Insmed(INSM.US)$ Phase 3
$GlycoMimetics(GLYC.US)$ Phase 3
$Annexon(ANNX.US)$ Phase 3
$Lipocine(LPCN.US)$ Phase 3
$FibroGen(FGEN.US)$ Phase 3
$UroGen Pharma Ltd(URGN.US)$ Phase 3
$Lyra Therapeutics(LYRA.US)$ Phase 3
$Citius Pharmaceuticals(CTXR.US)$ Phase 3
$Jaguar Health(JAGX.US)$ Phas...

Analysts Notebook

Apr 3 14:32

ColumnsWells Fargo's Tactical Longs and Shorts for Q2: Bullish on Amazon, Bearish on Tesla

The Wells Fargo equity team identified 14 high-conviction, catalyst-driven stock opportunities for the second quarter, including two Magnificent 7 names: Amazon and Tesla.
The list, updated each quarter, indicates where analysts "see significant Q2 24 catalysts that could drive meaningful upside or downside."
The list includes 10 Long (or Overweight) trades and 4 Short (or Underweight) trades:
$Amazon(AMZN.US)$ ,$Annexon(ANNX.US)$ ,...

Meltyy

Apr 1 15:47

Biotech Stock Catalyst Watchlist

🎯 Ph 3 readouts in Q2 2024...
$Intra-Cellular Therapies(ITCI.US)$ Phase 3
$CG Oncology(CGON.US)$ Phase 3
$Hutchmed (China)(HCM.US)$ Phase 3
$Viracta Therapeutics(VIRX.US)$ Phase 3
$GlycoMimetics(GLYC.US)$ Phase 3
$Annexon(ANNX.US)$ Phase 3
$Lipocine(LPCN.US)$ Phase 3
$FibroGen(FGEN.US)$ Phase 3
$UroGen Pharma Ltd(URGN.US)$ Phase 3
$Lyra Therapeutics(LYRA.US)$ Phase 3
$Citius Pharmaceuticals(CTXR.US)$ Phase 3
$Marinus Pharmaceuticals(MRNS.US)$ Phase 3
$BioCardia(BCDA.US)$ Phase 3...

Moomoo AI

Jan 22 22:25

Insiders at Insmed selling shares may indicate they believe the shares are overpriced. Some alignment exists between management and smaller shareholders, but lack of recent insider buying and net selling over the past year raises concerns.

Insmed Insiders Sold US$2.2m Of Shares Suggesting Hesitancy

Moomoo AI

Dec 18, 2023 21:18

Insmed's overvaluation and slower than average forecasted revenue growth raise investors' concern. Despite hopes for a turnaround, analysts express less confidence, indicating risks for shareholders and potential investors.